Royalty Pharma plc (RPRX)

Royalty Pharma Revenue

Royalty Pharma had revenue of $609.29M in the quarter ending September 30, 2025, with 7.90% growth. This brings the company's revenue in the last twelve months to $2.35B, up 3.70% year-over-year. In the year 2024, Royalty Pharma had annual revenue of $2.26B, down -3.86%.

• Revenue (ttm): $2.35B
• Revenue Growth: +3.70%
• P/S Ratio: 7.34
• Revenue / Employee: $23,735,798
• Employees: 99
• Market Cap: 22.93B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.26B	-90.98M	-3.86%
Dec 31, 2023	2.35B	117.34M	5.24%
Dec 31, 2022	2.24B	-52.25M	-2.28%
Dec 31, 2021	2.29B	167.11M	7.87%
Dec 31, 2020	2.12B	308.10M	16.98%
Dec 31, 2019	1.81B	19.36M	1.08%
Dec 31, 2018	1.79B	196.96M	12.33%
Dec 31, 2017	1.60B	-	-